153 related articles for article (PubMed ID: 14689589)
1. Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer.
Fischer AH; Bardarov S; Jiang Z
J Cell Biochem; 2004 Jan; 91(1):170-84. PubMed ID: 14689589
[TBL] [Abstract][Full Text] [Related]
2. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
3. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
Zeng L; Kyprianou N
Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
[TBL] [Abstract][Full Text] [Related]
6. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
Epstein JI; Herawi M
J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
[TBL] [Abstract][Full Text] [Related]
7. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
[TBL] [Abstract][Full Text] [Related]
9. Prostatic intraepithelial neoplasia and prostate cancer: analytical evaluation.
Colanzi P; Santinelli A; Mazzucchelli R; Pomante R; Montironi R
Adv Clin Path; 1998 Oct; 2(4):271-284. PubMed ID: 10358369
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
11. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
12. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate.
Montironi R; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M
Nat Clin Pract Urol; 2007 Jun; 4(6):321-32. PubMed ID: 17551536
[TBL] [Abstract][Full Text] [Related]
14. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens.
Montironi R; Mazzucchelli R; Santinelli A; Scarpelli M; Beltran AL; Bostwick DG
Hum Pathol; 2005 Jun; 36(6):646-54. PubMed ID: 16021571
[TBL] [Abstract][Full Text] [Related]
15. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
16. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
[TBL] [Abstract][Full Text] [Related]
17. Alterations of p53 are common in early stage prostate cancer.
Downing SR; Russell PJ; Jackson P
Can J Urol; 2003 Aug; 10(4):1924-33. PubMed ID: 14503938
[TBL] [Abstract][Full Text] [Related]
18. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
19. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
20. Cytological features of prostatic intraepithelial neoplasia.
Valdman A; Jonmarker S; Ekman P; Egevad L
Diagn Cytopathol; 2006 May; 34(5):317-22. PubMed ID: 16604550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
